Israel Provoking Global Drug Patent Dispute, E.U. Warns

Law360, New York (October 14, 2004, 12:00 AM EDT) -- A delegation from the European Union has told Israel that its drug patent policy is provoking “a dispute not between Israel and the U.S., but with the Western world.”

A 20-member forum of European economic attaches in Israel met at the European Union offices in Israel to discuss Israel's proposals for protecting pharmaceutical data exclusivity, according to local media reports.

The European Union, echoing similar sentiments by the U.S., is reported to be extremely dissatisfied with Israel's to limit protection of pharmaceutical information to marketing exclusivity...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.